Compassionate Use Program – Singapore (HSA)
HSA Compassionate Use Application with supporting clinical documentationAdministrative14 days
Description & Eligibility
The Health Sciences Authority allows import and use of unregistered therapeutic products for named patients with serious diseases under the Compassionate Use Programme. Applications must demonstrate that standard treatments have failed or are unsuitable.
Eligibility Criteria
Patients with life-threatening conditions or serious diseases where registered treatments are ineffective or unavailable
Legal Reference / Source
Health Products Act, HSA Guidance on Compassionate Use 2023
Compassionate Use Program – Singapore (HSA)
| Approval Form | HSA Compassionate Use Application with supporting clinical documentation |
| Timeline | 14 days |
| Legal Status | Administrative |
| Source Ref. | Health Products Act, HSA Guidance on Compassionate Use 2023 |
| Countries | 0 countries |
Compliance Check
Legal Review3/21/2026
Global ValidityVerified